KR20020006510A - 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물 - Google Patents

세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물 Download PDF

Info

Publication number
KR20020006510A
KR20020006510A KR1020017000477A KR20017000477A KR20020006510A KR 20020006510 A KR20020006510 A KR 20020006510A KR 1020017000477 A KR1020017000477 A KR 1020017000477A KR 20017000477 A KR20017000477 A KR 20017000477A KR 20020006510 A KR20020006510 A KR 20020006510A
Authority
KR
South Korea
Prior art keywords
group
treatment
protocol
oncol
clin
Prior art date
Application number
KR1020017000477A
Other languages
English (en)
Korean (ko)
Inventor
프랜시스 다로
로버트 키스
아맨드 프리드만
Original Assignee
파.세 라퐁
라보라뜨와르 엘르 라퐁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파.세 라퐁, 라보라뜨와르 엘르 라퐁 filed Critical 파.세 라퐁
Publication of KR20020006510A publication Critical patent/KR20020006510A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
KR1020017000477A 1998-07-15 1999-07-13 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물 KR20020006510A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/09059 1998-07-15
FR9809059A FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
PCT/FR1999/001715 WO2000003707A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base d'isoflavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (1)

Publication Number Publication Date
KR20020006510A true KR20020006510A (ko) 2002-01-19

Family

ID=9528649

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017000477A KR20020006510A (ko) 1998-07-15 1999-07-13 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물

Country Status (11)

Country Link
EP (1) EP1096929A1 (ja)
JP (1) JP2002520357A (ja)
KR (1) KR20020006510A (ja)
CN (1) CN1139383C (ja)
AU (1) AU761417B2 (ja)
BR (1) BR9912817A (ja)
CA (1) CA2337256A1 (ja)
EA (1) EA200100141A1 (ja)
FR (1) FR2781154B1 (ja)
IL (1) IL140580A0 (ja)
WO (1) WO2000003707A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
EP1487434B1 (en) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
DE10337863A1 (de) * 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
CA2590048C (en) 2007-05-23 2013-07-16 Institut National De La Recherche Scientifique Cytosine nucleoside analogs and isoflavones and uses thereof
CN106265669A (zh) * 2016-08-04 2017-01-04 大连理工大学 大豆苷元与10‑羟基喜树碱的药物组合及其应用
CN113842387A (zh) * 2021-11-19 2021-12-28 大连理工大学盘锦产业技术研究院 10-羟基喜树碱与鹰嘴豆芽素a的药物组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
GB9621757D0 (en) * 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions

Also Published As

Publication number Publication date
AU761417B2 (en) 2003-06-05
WO2000003707A1 (fr) 2000-01-27
IL140580A0 (en) 2002-02-10
CA2337256A1 (en) 2000-01-27
CN1312712A (zh) 2001-09-12
CN1139383C (zh) 2004-02-25
FR2781154A1 (fr) 2000-01-21
FR2781154B1 (fr) 2001-09-07
JP2002520357A (ja) 2002-07-09
EP1096929A1 (fr) 2001-05-09
BR9912817A (pt) 2001-05-08
AU4628299A (en) 2000-02-07
EA200100141A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
Fedier et al. Resistance to topoisomerase poisons due to loss of DNA mismatch repair
JP5687411B2 (ja) 固形腫瘍のための定率配合薬の治療
KR20010071859A (ko) 2-퀴놀론을 포함하는 약제학적 조성물
US6537990B1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
EP1478355B1 (en) Antitumor compositions containing taxane derivatives
JP2002541200A (ja) 癌の処置のための方法および組成物
CN104968358B (zh) 涉及粘液素的疾病治疗
EP1786440A2 (en) Treatments of refractory cancers using na+/k+-atpase inhibitors
EP1067941A1 (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
KR20020006510A (ko) 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물
KR20020003349A (ko) 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물
Bharti et al. Pathways linked to cancer chemoresistance and their targeting by nutraceuticals
Spriggs et al. Taxol administered as a 120 hour infusion
EP2033640A2 (en) Beta-lapachone for the treatment of lung cancer
US20070043110A1 (en) Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins
Giaccone New drugs in non-small cell lung cancer. An overview
MXPA01000389A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
EP2033638A2 (en) Beta-lapachone for the treatment of pancreatic cancer
MXPA01000387A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
Papakotsi Enhancing GDF1 Expression with Devil’s Club (Oplopanax horridus) Extracts in Acute Myeloid Leukemia
EP2033639A2 (en) Beta-lapachone for the treatment of colon cancer
Tsuchida et al. Topotecan and irinotecan in the treatment of pediatric solid tumors
XIAOXIA Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid